Determinants of care costs of patients with dementia or cognitive impairment

Alzheimer Disease and Associated Disorders

Volumn 27, Issue 1, 2013, Pages 30-36

  Handels, Ron L H ^a   Wolfs, Claire A G ^a   Aalten, Pauline ^a   Verhey, Frans R J ^a   Severens, Johan L ^b,c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Alzheimer disease; caregiver burden; cost of illness study; decision analytic modeling; dementia; economics

Indexed keywords

AGED; ARTICLE; CAREGIVER BURDEN; COGNITION; COGNITIVE DEFECT; COST OF ILLNESS; DAILY LIFE ACTIVITY; DEMENTIA; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SOCIAL ENVIRONMENT; STUDY DESIGN;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; CAREGIVERS; COGNITION DISORDERS; DECISION SUPPORT TECHNIQUES; DEMENTIA; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED;

EID: 84874282687     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e318242da1d     Document Type: Article

References (41)

1. Wimo A, Prince M. World Alzheimer Report 2010 The Global Economic Impact of Dementia. 2010. Available at: http:// www.alz.co.uk/research/worldreport/. Accessed October 1, 2010.
2. Briggs AH, Claxton K, Sculpher MJ. Decision Modelling for Health Economic Evaluation. Oxford: Oxford University Press; 2006.
3. Tarricone R. Cost-of-illness analysis. What room in health economics? Health Policy. 2006;77:51-63.
4. Jonsson L, Wimo A. The cost of dementia in Europe: a review of the evidence, and methodological considerations. Pharmacoeconomics. 2009;27:391-403.
5. Quentin W, Riedel-Heller SG, Luppa M, et al. Cost-of-illness studies of dementia: a systematic review focusing on stage dependency of costs. Acta Psychiatr Scand. 2009;121:243-259.
6. Wimo A, Jonsson L, Gustavsson A, et al. The economic impact of dementia in Europe in 2008-cost estimates from the Eurocode project. Int J Geriatr Psychiatry. 2011;26:825-832.
7. Coduras A, Rabasa I, Frank A, et al. Prospective one-year cost-of-illness study in a cohort of patients with dementia of Alzheimer's disease type in Spain: The ECO Study. J Alzheimers Dis. 2009;19:601-615.
8. Cohen JT, Neumann PJ. Decision analytic models for Alzheimer's disease: state of the art and future directions. Alzheimers Dement. 2008;4:212-222.
9. Green C. Modelling disease progression in Alzheimer's disease: a review of modelling methods used for cost-effectiveness analysis. Pharmacoeconomics. 2007;25:735-750.
10. Wolfs CA, Dirksen CD, Kessels A, et al. Economic evaluation of an integrated diagnostic approach for psychogeriatric patients: results of a randomized controlled trial. Arch Gen Psychiatry. 2009;66:313-323.
11. Wolfs CA, Kessels A, Dirksen CD, et al. Integrated multidisciplinary diagnostic approach for dementia care: randomised controlled trial. Br J Psychiatry. 2008;192:300-305.
12. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
13. Cummings JL, McPherson S. Neuropsychiatric assessment of Alzheimer's disease and related dementias. Aging (Milano). 2001;13:240-246.
14. Lawton MP, Brody EM. Assessment of older people: selfmaintaining and instrumental activities of daily living. Gerontologist. 1969;9:179-186.
15. EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy. 1990;16: 199-208.
16. Pot AM, van Dyck R, Deeg DJ. Perceived stress caused by informal caregiving. Construction of a scale. Tijdschr Gerontol Geriatr. 1995;26:214-219.
17. American Psychiatric Association. Diagnostic Criteria From DSM-IV-TR. Washington, DC: American Psychiatric Association; 2000.
18. Oostenbrink JBKM, Rutten FFH. Manual for costing: methods and standard costs for economic evaluations in health care. Amstelveen, The Netherlands: College voor zorgverzekeringen; 2004. [in Ducth].
19. van den Berg B, Al M, Brouwer W, et al. Economic valuation of informal care: the conjoint measurement method applied to informal caregiving. Soc Sci Med. 2005;61:1342-1355.
20. van den Berg B, Brouwer W, van Exel J, et al. Economic valuation of informal care: lessons from the application of the opportunity costs and proxy good methods. Soc Sci Med. 2006;62:835-845.
21. Briggs AH, Claxton K, Sculpher MJ. Decision Modelling for Health Economic Evaluation. Oxford: Oxford University Press; 2006.
22. Tabachnick BG, Fidell LS. Using Multivariate Statistics. 4th ed. Boston, MA: Allyn and Bacon; 2001.
23. Wimo A, von Strauss E, Nordberg G, et al. Time spent on informal and formal care giving for persons with dementia in Sweden. Health Policy. 2002;61:255-268.
24. Harrow BS, Mahoney DF, Mendelsohn AB, et al. Variation in cost of informal caregiving and formal-service use for people with Alzheimer's disease. Am J Alzheimers Dis Other Demen. 2004;19:299-308.
25. Jones M. Models for Health Care. University of York. Available at: http://www.york.ac.uk/res/herc/documents/wp/ 10-01.pdf. Accessed November 15, 2011.
26. Gaugler JE, Yu F, Krichbaum K, et al. Predictors of nursing home admission for persons with dementia. Med Care. 2009; 47:191-198.
27. Connell CM, Janevic MR, Gallant MP. The costs of caring: impact of dementia on family caregivers. J Geriatr Psychiatry Neurol. 2001;14:179-187.
28. Jonsson L, Eriksdotter Jonhagen M, Kilander L, et al. Determinants of costs of care for patients with Alzheimer's disease. Int J Geriatr Psychiatry. 2006;21:449-459.
29. Wolstenholme J, Fenn P, Gray A, et al. Estimating the relationship between disease progression and cost of care in dementia. Br J Psychiatry. 2002;181:36-42.
30. Herrmann N, Lanctot KL, Sambrook R, et al. The contribution of neuropsychiatric symptoms to the cost of dementia care. Int J Geriatr Psychiatry. 2006;21:972-976.
31. Murman DL, Chen Q, Powell MC, et al. The incremental direct costs associated with behavioral symptoms in AD. Neurology. 2002;59:1721-1729.
32. de Vugt ME, Stevens F, Aalten P, et al. A prospective study of the effects of behavioral symptoms on the institutionalization of patients with dementia. Int Psychogeriatr. 2005;17:577-589.
33. Scuvee-Moreau J, Kurz X, Dresse A. The economic impact of dementia in Belgium: results of the National Dementia Economic Study (NADES). Acta Neurol Belg. 2002;102: 104-113.
34. Souetre E, Thwaites RM, Yeardley HL. Economic impact of Alzheimer's disease in the United Kingdom. Cost of care and disease severity for non-institutionalised patients with Alzheimer's disease. Br J Psychiatry. 1999;174:51-55.
35. Wimo A, Winblad B, Jonsson L. The worldwide societal costs of dementia: estimates for 2009. Alzheimers Dement. 2010;6: 98-103.
36. Tamim H, McCusker J, Dendukuri N. Proxy reporting of quality of life using the EQ-5D. Med Care. 2002;40:1186-1195.
37. Sculpher MJ, Pang FS, Manca A, et al. Generalisability in economic evaluation studies in healthcare: a review and case studies. Health Technol Assess. 2004;8:iii-iv. 1-192.
38. Caro JJ, Getsios D, Migliaccio-Walle K, et al. Assessment of health economics in Alzheimer's disease (AHEAD) based on need for full-time care. Neurology. 2001;57:964-971.
39. Francois C, Sintonen H, Sulkava R, et al. Cost effectiveness of memantine in moderately severe to severe Alzheimer's disease: a Markov model in Finland. Clin Drug Investig. 2004;24: 373-384.
40. Ward A, Caro JJ, Getsios D, et al. Assessment of health economics in Alzheimer's disease (AHEAD): treatment with galantamine in the UK. Int J Geriatr Psychiatry. 2003;18: 740-747.
41. Torti FM Jr, Gwyther LP, Reed SD, et al. A multinational review of recent trends and reports in dementia caregiver burden. Alzheimer Dis Assoc Disord. 2004;18:99-109.